Single-Dose Darbepoetin Administration to Anemic Preterm Neonates

Pharmacokinetics of Novel Erythropoiesis Stimulating Protein Compared with Epoetin Alfa in Dialysis Patients

Iain C. Macdougall, Stephen J. Gray, Orlaith Elston et al. · Journal of the American Society of Nephrology · 1999 · 434 citations

Medicine, Pharmacokinetics, Pharmacology +13

Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin

Joan C. Egrie, Erik Dwyer, Jeffrey K. Browne et al. · Experimental Hematology · 2003 · 419 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +2

Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study

Dusan Kotasek, G. Steger, Wylam Faught et al. · European Journal of Cancer · 2003 · 140 citations

Medicine, Oncology, Pharmacology +6

Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.

Michael P. Meyer, J. Meyer, A. Commerford et al. · PubMed · 1994 · 127 citations

Medicine, Pediatrics, Pharmacotherapy +16

The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: A randomized, double-blind, placebo-controlled study

Robin K. Ohls, Jenny Harcum, Kurt Schibler et al. · The Journal of Pediatrics · 1997 · 120 citations

Medicine, Hematology, Pediatrics +16